Search Results

Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing applications, today announced its speaker lineup and activities for the upcoming ISCT 2024, the annual meeting of the International Society for Cell & Gene Therapy, taking place May 29 – June 1 in Vancouver, British Columbia.

Xcell Biosciences Inc. and AmplifyBio today announced the launch of a partnership designed to streamline and improve the manufacturing process for engineered T-cell receptor (TCR) therapies targeting solid tumors.

Xcell Biosciences Inc. today announced it has added new elements to its research collaboration agreement with Labcorp, a global leader of innovative and comprehensive laboratory services.

Xcell Biosciences Inc., an instrumentation company focused on cell and gene therapy applications, announced the formation of a new scientific and business advisory board composed of some of the leading minds in the industry.

Xcell Biosciences, Inc. today announced a collaboration with ElevateBio, LLC (ElevateBio), through which the companies aim to explore novel approaches to improving therapeutic potency of cell and gene therapies.

Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has achieved key milestones in its R&D collaboration with Labcorp, a global leader of innovative and comprehensive laboratory services, aimed at driving innovation in the development and validation of cell and gene therapies.

KUBTEC® Scientific, a leading digital X-ray imaging and irradiation system manufacturer, launched the latest advancement in benchtop irradiation systems - the XCELL® 180 X-ray Irradiator.

Xcell Biosciences Inc. today announced a collaboration to improve manufacturing and analytic procedures used to develop personalized cell and gene therapies for cancer patients.